Thirdly, using genetic instruments at the PCSK9 locus extracted from a GWAS of LDL-c, liver-derived PCSK9 expression, and circulating PCSK9 protein, this work focuses on the indirect association between PCSK9 inhibition and prostate cancer risk. The gene discussed is PCSK9; the disease is prostate cancer.